Naxos disease presenting with ventricular tachycardia and troponin elevation

Heart and Vessels

Volumn 24, Issue 1, 2009, Pages 63-65

  Lazaros, George ^a   Anastasakis, Aris ^a   Tsiachris, Dimitris ^a   Dilaveris, Polychronis ^a,b   Protonotarios, Nikos ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy; Myocardial necrosis; Myocarditis; Naxos disease; Ventricular tachycardia

Indexed keywords

TROPONIN I;

ADULT; ARTICLE; CASE REPORT; DEFIBRILLATOR; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HAIR; HEART DILATATION; HEART EJECTION FRACTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE DILATATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOKINESIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PALMOPLANTAR KERATODERMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QRS COMPLEX; QT INTERVAL; SINUS RHYTHM; T WAVE INVERSION; WOOLLY HAIR;

ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; HAIR DISEASES; HUMANS; KERATODERMA, PALMOPLANTAR; MAGNETIC RESONANCE IMAGING; MALE; TACHYCARDIA, VENTRICULAR; TROPONIN I;

EID: 59049084209     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1082-5     Document Type: Article

References (14)

1. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, McKenna WJ (2000) Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355:2119-2124
2. Protonotarios N, Tsatsopoulou A, Anastasakis A, Sevdalis E, McKoy G, Stratos K, Gatzoulis K, Tentolouris K, Spiliopoulou C, Panagiotakos D, McKenna W, Toutouzas P (2001) Genotypephenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin. J Am Coll Cardiol 38:1477-1484
3. Protonotarios NI, Tsatsopoulou AA, Gatzoulis KA (2002) Arrhythmogenic right ventricular cardiomyopathy caused by a deletion in plakoglobin (Naxos disease). Card Electrophysiol Rev 6:72-80
4. Protonotarios N, Tsatsopoulou A (2004) Arrhythmogenic right ventricular cardiomyopathy/dysplasia and Naxos disease. Hellenic J Cardiol 45:370-378
5. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F (1994) Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 71:215-218
6. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M (1996) Arrhythmogenic right ventricular cardiomyopathy: Dysplasia, dystrophy or myocarditis? Circulation 94:983-991
7. Thiene G, Corrado D, Nava A, Rossi L, Poletti A, Boffa GM, Daliento L, Pennelli N (1991) Right ventricular cardiomyopathy: Is there evidence of an inflammatory aetiology? Eur Heart J Suppl D:22-25
8. Valente M, Calabrese F, Thiene G, Angelini A, Basso C, Nava A, Rossi L (1998) In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol 15:479-484
9. Nava A, Bauce B, Basso C, Muriago M, Rampazzo A, Villanova C, Daliento L, Buja G, Corrado D, Danieli GA, Thiene G (2000) Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy J Am Coll Cardiol 36:2226-2233
10. Fontaine G, Fontaliran F, Rosas Andrade F, Velasquez E, Tonet J, Jouven X, Fujioka Y, Frank R (1995) The arrhythmogenic right ventricle. Dysplasia versus cardiomyopathy. Heart Vessels 10:227-235
11. American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society (2006) ACC/AHA/ ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 27:2099-2140
12. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU, Igidbashian D, Raviele A, Disertori M, Zanotto G, Verlato R, Vergara G, Delise P, Turrini P, Basso C, Naccarella F, Maddalena F, Estes NA 3rd, Buja G, Thiene G (2003) Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108:3084-3091
13. Anastasakis A, McKenna W, Stefanadis C (2006) Prevention of sudden cardiac death in the young: Targeted evaluation of those at risk. Hellenic J Cardiol 47:251-254
14. Boriani G, Artale P, Biffi M, Martignani C, Frabetti L, Valzania C, Diemberger I, Ziacchi M, Bertini M, Rapezzi C, Parlapiano M, Branzi A (2007) Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Vessels 22:184-192